• Scientific Sessions

  • Programming

    Live Sessions

    Session CH.AOS.463
    226 – Impact of Norwood shunt type on cardiac function and clinical outcomes in survivors to early adolescence with hypoplastic left heart syndrome and other single right ventricular anomalies: A report from the single ventricle reconstruction (SVR) III study
    Caren Goldberg, M.D.
    8:12 – 8:24 a.m. ET

    LATE-BREAKING Session LBS.01
    226 Evaluating the benefit of concomitant tricuspid repair during mitral valve surgery
    Annetine C. Gelijns, Ph.D., Marissa Miller, D.V.M., Wendy Taddei-Peters, Ph.D., Neal Jeffries, Ph.D.
    9:43 – 9:53 a.m. ET

    LATE-BREAKING Session LBS.01
    Efficacy and safety of an external support device for saphenous vein coronary bypass grafts: The VEST trial
    10:11 – 10:19 a.m. ET

    Session CS.ME.1188
    Cardiovascular health after 10 years: What have we learned and what is the future?
    Moderator: David Goff, M.D., Ph.D.
    11:00 a.m. – 12:15 p.m. ET

    Session LS.08
    National Heart, Lung, and Blood Institute Small Business Grant Program: Live Virtual Pitch Event
    Recovery Force, Optima Integrated Health, Cornovus Pharmaceuticals, Elucid Bio, Exhalix, 3DT Holdings
    3:00  – 4:30 p.m. ET

    Session FS.02
    Whole-heart quantification and characterization of coronary atherosclerotic burden and risk of major adverse cardiovascular events: The Ischemia Trial
    James Min, M.D.
    4:58 – 5:06 p.m. ET

    On-Demand Sessions

    Session QU.RFO.16
    Neighborhood perception is associated with physical activity and nutrition self-efficacy among African Americans: The Washington, DC cardiovascular health and needs Assessment
    Foster Oseh Baah, Ph.D., Tiffany Powell-Wiley, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session PH.AOS.399
    V180 – Plasma cell-free DNA predicts survival and maps tissue-specific sources of injury in pulmonary arterial hypertension
    Michael Solomon, M.D., Mehdi Pirooznia, M.D., Ph.D., Sean Agbor-Enoh M.D., Ph.D., Manreet Kanwar, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session AT.AOS.378
    280 – Regulation of blood pressure by smooth muscle TRPV4 channels under normal and hypertensive conditions
    Yen-Lin Chen, Ph.D.
    8:00 a.m. – 5:30 p.m. ET

    Session EP.CVS.389
    NHLBI’s vision for preserving cardiovascular health across the life course
    David Goff, M.D., Ph.D.
    8:00 a.m. – 5:30 p.m. ET

    Session EP.AOS.424
    Pursuing a heart-healthy planet
    David Goff, M.D., Ph.D.
    8:00 a.m. – 5:30 p.m. ET

    Session LF.EC.55
    Meet the experts: Leaders of NHLBI and NINDS-funded cohorts
    NHLBI: ARIC, CARDIA, CHS, FHS, HCHS/SOL,JHS, nuMoM2b, RURAL; NCI: HPFS; NINDS/NIA: REGARDS
    8:00 a.m. – 5:30 p.m. ET

    Session AT.CVS.245
    Single-cell RNA sequencing reveals heterogeneity of vascular cells in early stage murine abdominal aortic aneurysm
    Bo Liu, Ph.D.
    8:00 a.m. – 5:30 p.m. ET

    Session CM.RFO.22
    RF66 – Multidimensional sleep health is associated with cardiometabolic health in a nationally representative sample of US adults
    Nour Makarem, Ph.D.
    8:00 a.m. – 5:30 p.m. ET

    Session HF.CVS.279
    How funding sponsors are supporting new methods of achieving equity
    George Mensah, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session IM.CVS.392
    Whither disparities in hypertrophy/heart failure
    George Mensah, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session LF.CVS.250
    Role of the community in cardiometabolic care – impact of infrastructure and communities on health
    Tiffany Powell-Wiley, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session EA.AOS.456
    195 – Race-specific models to predict in-hospital mortality in patients with heart failure using machine learning: The American Heart Association get with the guidelines registry
    Tiffany Powell-Wiley, M.D., David Kao, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session EP.RFO.15
    RF41 – Racial and gender differences in lifetime healthcare costs across cardiovascular risk factors
    Tiffany Powell-Wiley, M.D., Rohan Khera, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session GE.APS.1221: P1391
    Epigenetic risk score capturing alcohol consumption is not associated with cardiac structure and function: The Framingham Heart Study
    Helena Bui, Amena Keshawarz, Ph.D., Vasan Ramachandran, M.D., Daniel Levy, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session PH.CVS.329
    Putting PVDOMICS into practice
    Moderator: Lei Xiao, , M.D., Ph.D.
    8:00 a.m. – 5:00 p.m. ET

    Session VA.RFO.20
    Thrombosis, antithrombotics, and antiplatelets
    Moderator: Yogendra Kanthi, M.D.
    8:00 a.m. – 5:00 p.m. ET

    Session CA.ME.486 – Organ on Demand: 3D Printing for CVD
    In situ Expansion, Differentiation, and Electromechanical Coupling of Human Cardiac Muscle in a 3D Bioprinted, Chambered Organoid 
    Brenda Ogle, Ph.D.
    5:00 – 5:15 p.m. ET

    Session MP.AOS.450
    V17 – Plasma Proteomic Profiling of Endurance Exercise Identified Changes in Extracellular Matrix Biologly Associated with Adaptations in Maximal Oxygen Uptake
    Prashant Rao, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Poster Sessions

    Session DD.APS.01: P773
    Novel fumarate prodrug rescues cardiomyopathy and motor function in Friedreich’s Ataxia 
    Elena Dedkova, Ph.D.
    8:00 a.m. – 5:30 p.m. ET

    Session AT.APS.02: P121
    Resolution of inflammation via Rvd1/fpr2 signaling in abdominal aortic aneurysms
    Amanda Filiberto, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session AT.APS.02: P114
    Isolated liver perfusion and electron microscopy reveal defect in Vldl lipidation associated with inactivation of Tm6sf2
    Helen Hobbs, M.D.
    8:00 a.m. – 5:30 p.m. ET

    Session AT.APS.01: P105
    Plasma apolipoprotein C3 is negatively associated with high lipoprotein(a) plasma levels in healthy volunteers
    Anastasiya Matveyenko, Gissette Reyes-Soffer, M.D.
    11:00 a.m. – 12:00 p.m. ET

    Session AT.APS.01
    Total lipoprotein lipase deficiency does not impact atherosclerosis development in low density lipoprotein receptor deficient mice
    Debapriya Basu, Ira Goldberg, M.D.
    11:00 a.m. – 12:00 p.m. ET

    Session SA.APS.02: P2881
    Insulin-like growth factor binding protein 2 is a novel marker of early smooth muscle cell phenotype modulation in thoracic aortic aneurysm
    Albert J. Pedroza, M.D.
    11:00 a.m. – 12:00 p.m. ET

    Sunday, November 14, 2021

    Live Sessions

    Session ReSS.AOS.03
    RO15 – A randomized trial of a physiologic-directed point-of-care training and debriefing intervention for cardiac arrest
    Robert Sutton, M.D.
    8:24 – 8:36 a.m. ET

    LATE-BREAKING Session LBS.03
    Posterior left pericardiotomy reduces postoperative atrial fibrillation after cardiac surgery
    Mario Gaudino, M.D.
    8:28 – 8:38 a.m. ET

    Session AT.ME.238
    Paradigm shift of understanding human atherosclerosis: Single-cell immune landscape
    Chiara Giannarelli, M.D., Ph.D.
    5:00 – 5:10 p.m. ET

    Poster Sessions

    Session AT.APS.03: P130
    Endothelial pannexin1-TRPV4 signaling regulates pulmonary arterial pressure
    Rupak Mukherjee Ph.D., Jeffrey Jones, Ph.D., Jean Ruddy, M.D.
    11:00 a.m. – 12:00 p.m. ET

    Session AT.APS.03: P130
    Endothelial pannexin1-TRPV4 signaling regulates pulmonary arterial pressure
    Zdravka Daneva, Ph.D.
    11:00 a.m. – 12:00 p.m. ET

    Session CA.APS.05
    New horizons in cardioprotection
    Elizabeth Murphy, Ph.D.
    11:00 a.m. – 12:00 p.m. ET

    Session CH.APS.07: P599
    Establishing normal pediatric aortic valve cusp effective height utilizing the Pediatric Heart Network normal echo Z score project echocardiograms
    Ben Goot, M.D.
    11:00 a.m. – 12:00 p.m. ET

    Session EP.APS.11: P1162
    Are CAC scores less valuable for patients of low socioeconomic status? A Dallas Heart Study analysis
    Tiffany Powell-Wiley, M.D.
    11:00 a.m. – 12:00 p.m. ET

    Session SA.APS.05: P2905
    Health status outcomes of percutaneous coronary intervention and coronary artery bypass grating in stable coronary disease: secondary analysis of the ISCHEMIA Trial
    Chetan Huded, M.D.
    3:30 – 4:30 p.m. ET

    Session GE.APS.04: P1320
    Identification of allele-specific gene expression in association with blood pressure
    Amena Keshawarz, Ph.D.
    3:30 – 4:30 p.m. ET

    Monday, November 15, 2021

    Live Sessions

    Session CE.EC.405
    Customizing your career: an open discussion with distinguished panelists
    Moderator: Renee Wong, Ph.D.
    11:00 a.m. – 12:00 p.m. ET

    LATE-BREAKING Session LBS.07
    P2y12 inhibitors in noncritically ill hospitalized patients with COVID-19
    Judith Hochman, M.D., Jeff Berger, M.D.
    11:11 – 11:19 a.m. ET

    Poster Sessions

    Session QCOR.APS.04: P2664
    Association of medical non-adherence to health status outcomes in the ISCHEMIA Trial
    Raul Garcia, Ph.D.
    8:00 a.m. – 5:00 p.m. ET

    Session AC.APS.05: P51
    Heterogeneity of benefit on quality of life with an invasive versus conservative strategy for chronic coronary disease. Results from the ISCHEMIA Trial
    Suzanne Arnold
    11:00 a.m. – 12:00 p.m. ET

    Session CH.APS.12: P650
    Global longitudinal strain and longitudinal early diastolic strain rate may identify those Williams syndrome patients at risk of cardiomyopathy development
    Marie Carillo, M.D.
    1:30 – 2:30 p.m. ET

Author